Biological Intellectual Property Protection Act of 2025

This bill restricts the export of synthetic DNA and RNA sequences to foreign entities of concern to protect U.S. intellectual property and sensitive information related to synthetic biology.

Sec. 3, License requirement to protect U.S. intellectual property and sensitive information related to synthetic biology: Within one year of enactment, the Secretary must require a license for the export, reexport, or in-country transfer to a foreign entity of concern of a digital sequence of synthetic DNA or RNA designed by humans or artificial intelligence systems. This requirement does not apply to certain information already exempt under existing export regulations. The section defines key terms: 'digital sequence' as a binary file representing DNA or RNA molecule symbols; 'foreign country of concern' as defined in another law; 'foreign entity of concern' as a government entity of such a country, a person under its jurisdiction, or a person owned or controlled by such entities; and 'synthetic DNA or RNA' as constructed or synthesized nucleic acid molecules that can replicate or base pair with natural ones.